Pharmaceutical Industry Information Portal

HomeNews

News

Egyptian company SOLYPHAR will build a pharmaceutical company in Uzbekistan

It is envisaged to implement the project in three stages from 2021 to 2024, the amount of investment from the company "SOLYPHAR" will be more than 20 million US dollars, in accordance to the international GMP standards.

Sputnik V demonstrates 94.3% efficacy during the vaccination campaign in Bahrain

An efficacy study was conducted in Bahrain in accordance with WHO guidelines involving more than 5,000 subjects. Overall efficacy beyond 14 days after administering the second dose was estimated at 94.3%.

ROSATOM to supply Brazil with promising isotopes needed in Nuclear Medicine

Isotope JSC (a part of Rusatom Healthcare JSC, Rosatom’s radiation technologies integrator) has signed a five-year contract with Brazil’s Nuclear and Energy Research Institute...

R-Pharm announces the signing of a distribution agreement with PHC Europe B.V.

Etten-Leur, Tokyo, Moscow, June 9, 2021. R-Pharm Group announces the signing of a distribution agreement with PHC Europe B.V., one of the largest suppliers...

FDA Approves Pfizer’s Pneumococcal 20-valent Conjugate Vaccine For Adults

The U.S. Food and Drug Administration has approved Pfizer Inc.'s (PFE) PREVNAR 20 or Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae or pneumococcus serotypes in the vaccine in adults ages 18 years and older.

Ministry of Health of the Russian Federation issues permit for post-registration trials of CoviVac

The Russian Health Ministry has issued a permit to conduct the post-registration clinical trials of the CoviVac shot against the coronavirus infection with the...
spot_img

Expert Articles

spot_img